Hofseth Biocare ASA
OSE:HBC

Watchlist Manager
Hofseth Biocare ASA Logo
Hofseth Biocare ASA
OSE:HBC
Watchlist
Price: 1.43 NOK Market Closed
Market Cap: 565m NOK
Have any thoughts about
Hofseth Biocare ASA?
Write Note

Hofseth Biocare ASA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hofseth Biocare ASA
Cost of Revenue Peer Comparison

Comparables:
B
BGBIO
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Hofseth Biocare ASA
OSE:HBC
Cost of Revenue
-kr158.3m
CAGR 3-Years
-46%
CAGR 5-Years
-30%
CAGR 10-Years
-24%
B
Bergenbio ASA
OSE:BGBIO
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Cost of Revenue
-kr6.5m
CAGR 3-Years
-79%
CAGR 5-Years
20%
CAGR 10-Years
-5%
N
Nykode Therapeutics ASA
OSE:NYKD
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hofseth Biocare ASA's Cost of Revenue?
Cost of Revenue
-158.3m NOK

Based on the financial report for Jun 30, 2024, Hofseth Biocare ASA's Cost of Revenue amounts to -158.3m NOK.

What is Hofseth Biocare ASA's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-24%

Over the last year, the Cost of Revenue growth was -31%. The average annual Cost of Revenue growth rates for Hofseth Biocare ASA have been -46% over the past three years , -30% over the past five years , and -24% over the past ten years .

Back to Top